Back
HFA Premium Access

Functional and anatomical pulmonary arterial disease in patients with persistent pulmonary hypertension after left valve replacement according to the hemodynamic phenotype

Session: Moderated Poster session 3 - Novel treatment
Topic: Pulmonary Hypertension
Speaker: Professor E. Peris Domingo (Barcelona, ES)
Event: Heart Failure 2018

Congress Presentation

Add to my library

Like

About the speaker

Professor Enrique Peris Domingo

University Hospital Vall d'Hebron, Barcelona (Spain)
0 follower

6 more presentations in this session

Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin

Access
Like
Thumbnail

What proportion of patients with HFrEF might be candidates for Sacubitril-Valsartan?

Speaker: Doctor T. O connor (Dublin 9, IE)

Access
Abstract
Slides
Like
Thumbnail

Heart failure patients with reduced left ventricular ejection fraction, who reached 100% target dose of beta-blockers in randomized and observational studies

Speaker: Mrs M. Oyanguren Artola (Bilbao, ES)

Access
Abstract
Slides
Like
Thumbnail

Metabolic response to exercise training in heart failure with preserved ejection fraction

Speaker: Doctor M. Bahls (Greifswald, DE)

Access
Abstract
Like
Thumbnail

Adherence to ESC guidelines after hospital admission for heart failure in 22500 Dutch patients: 2001-2015

Speaker: Mrs W. Kruik-Kolloffel (Almelo, NL)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Moderated Poster session 3 - Novel treatment

Speakers: Professor E. Peris Domingo, Doctor T. O connor, Mrs M. Oyanguren Artola, Doctor M. Bahls, Mrs W. Kruik-Kolloffel
Access
Like
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources